CAS NO.259793-88-9 6-Bromo-3-hydroxypyrazine-2-carboxamide
Product Description
Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Favipiravir intermediates 6-Bromo-3-hydroxypyrazine-2-carboxamide (CAS NO. 259793-88-9) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation
Favipiravir, also known as T-705 or Avigan, is an antiviral drug being developed by Toyama Chemical (Fujifilm group) of Japan with activity against many RNA viruses. In February 2020 Favipiravir was being studied in China for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.
Product Image
Img 1
Send Inquiry to this Member
Related Products of this Company
This member assumes full responsibility for the content of this listing. DIYTrade accepts no responsibility whatsoever in respect of such content.
To report fraudulent or illegal content, please
click here.
China Suppliers Quick Searching:
,
